Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)

Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)

Abstract Purpose The goal of this study was to investigate the Liver Imaging Reporting and Data System (LI-RADS) v.2017 for the categorization of hepatocellular carcinomas (HCCs) with gadoxetic acid compared with gadopentetate dimeglumine-enhanced 1.5-T magnetic resonance imaging (MRI). Material and...

Full description

Bibliographic Details
Main Authors: Ying Ding, Sheng-xiang Rao, Wen-tao Wang, Cai-zhong Chen, Ren-chen Li, Mengsu Zeng
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Cancer Imaging
Subjects:
Gadoxetic acid
Gadopentetate dimeglumine
Magnetic resonance imaging
Liver imaging reporting and data system
Hepatocellular carcinoma
Online Access:http://link.springer.com/article/10.1186/s40644-018-0183-3

Internet

http://link.springer.com/article/10.1186/s40644-018-0183-3

Similar Items